HK1223853A1 - 骨質疏鬆症治療劑 - Google Patents
骨質疏鬆症治療劑Info
- Publication number
- HK1223853A1 HK1223853A1 HK16112322.6A HK16112322A HK1223853A1 HK 1223853 A1 HK1223853 A1 HK 1223853A1 HK 16112322 A HK16112322 A HK 16112322A HK 1223853 A1 HK1223853 A1 HK 1223853A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- osteoporosis
- therapeutic agent
- therapeutic
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/041,222 US9149471B2 (en) | 2013-09-30 | 2013-09-30 | Therapeutic agent for osteoporosis |
| PCT/JP2014/075804 WO2015046484A1 (ja) | 2013-09-30 | 2014-09-29 | 骨粗鬆症治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1223853A1 true HK1223853A1 (zh) | 2017-08-11 |
Family
ID=52743608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16112322.6A HK1223853A1 (zh) | 2013-09-30 | 2016-10-26 | 骨質疏鬆症治療劑 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9149471B2 (zh) |
| EP (1) | EP3053581B1 (zh) |
| JP (1) | JP6487845B2 (zh) |
| CN (2) | CN112870195A (zh) |
| ES (1) | ES2774773T3 (zh) |
| HK (1) | HK1223853A1 (zh) |
| TW (1) | TW201529070A (zh) |
| WO (1) | WO2015046484A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107614489B (zh) * | 2015-04-30 | 2021-05-11 | 大鹏药品工业株式会社 | 酰基硫脲化合物的甲磺酸盐及其晶体、以及它们的制造方法 |
| ES2928684T3 (es) | 2015-06-25 | 2022-11-21 | Taiho Pharmaceutical Co Ltd | Agente terapéutico para la fibrosis |
| CN110312511B (zh) | 2017-02-15 | 2023-10-27 | 大鹏药品工业株式会社 | 医药组合物 |
| AU2019342447A1 (en) | 2018-09-18 | 2021-04-08 | Taiho Pharmaceutical Co., Ltd. | Combination therapy of acylthiourea compound and abiraterone |
| TW202140426A (zh) | 2020-02-14 | 2021-11-01 | 日商大鵬藥品工業股份有限公司 | 醯基硫脲化合物的製造方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003039534A1 (en) * | 2001-11-08 | 2003-05-15 | Merck & Co., Inc. | Compositions and methods for treating osteoporosis |
| WO2004002524A1 (en) * | 2002-06-28 | 2004-01-08 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Placental growth factor as a target for the treatment of osteoporosis |
| CA2720552C (en) * | 2008-04-10 | 2016-06-14 | Taiho Pharmaceutical Co., Ltd. | Acylthiourea compound or salt thereof, and use thereof |
| JP2010215607A (ja) * | 2009-02-17 | 2010-09-30 | Naraken Chusho Kigyo Sien Center | 骨粗鬆症予防・治療剤および破骨細胞分化抑制剤 |
| WO2011008052A2 (ko) * | 2009-07-17 | 2011-01-20 | 한국생명공학연구원 | 콜포신 다로페이트를 포함하는 골 질환의 예방 또는 치료용 조성물 |
| TWI662962B (zh) * | 2011-11-08 | 2019-06-21 | 艾克塞里克斯公司 | 治療癌症之方法 |
| TWI594986B (zh) | 2011-12-28 | 2017-08-11 | Taiho Pharmaceutical Co Ltd | Antineoplastic agent effect enhancer |
| WO2013137382A1 (ja) * | 2012-03-15 | 2013-09-19 | 協和発酵バイオ株式会社 | 骨代謝改善剤 |
-
2013
- 2013-09-30 US US14/041,222 patent/US9149471B2/en active Active
-
2014
- 2014-09-29 JP JP2015539408A patent/JP6487845B2/ja active Active
- 2014-09-29 WO PCT/JP2014/075804 patent/WO2015046484A1/ja active Application Filing
- 2014-09-29 ES ES14849595T patent/ES2774773T3/es active Active
- 2014-09-29 EP EP14849595.5A patent/EP3053581B1/en active Active
- 2014-09-29 TW TW103133793A patent/TW201529070A/zh unknown
- 2014-09-29 CN CN202110371615.5A patent/CN112870195A/zh active Pending
- 2014-09-29 CN CN201480049594.3A patent/CN105530939A/zh active Pending
-
2016
- 2016-10-26 HK HK16112322.6A patent/HK1223853A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015046484A1 (ja) | 2015-04-02 |
| CN112870195A (zh) | 2021-06-01 |
| CN105530939A (zh) | 2016-04-27 |
| EP3053581B1 (en) | 2020-02-12 |
| JPWO2015046484A1 (ja) | 2017-03-09 |
| EP3053581A4 (en) | 2017-04-12 |
| US20150164879A1 (en) | 2015-06-18 |
| ES2774773T3 (es) | 2020-07-22 |
| US9149471B2 (en) | 2015-10-06 |
| JP6487845B2 (ja) | 2019-03-20 |
| EP3053581A1 (en) | 2016-08-10 |
| TW201529070A (zh) | 2015-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201321746D0 (en) | Therapeutic agents | |
| GB201321743D0 (en) | Therapeutic agents | |
| GB201321738D0 (en) | Therapeutic Agents | |
| GB201321736D0 (en) | Therapeutic agents | |
| GB201321729D0 (en) | Therapeutic agents | |
| GB201321733D0 (en) | Therapeutic agents | |
| GB201321728D0 (en) | Therapeutic agents | |
| GB201321739D0 (en) | Therapeutic agents | |
| GB201321730D0 (en) | Therapeutic agents | |
| GB201321741D0 (en) | Therapeutic agents | |
| GB201321740D0 (en) | Therapeutic agents | |
| GB201321732D0 (en) | Therapeutic agents | |
| GB201321734D0 (en) | Therapeutic Agents | |
| GB201321737D0 (en) | Therapeutic Agents | |
| GB201321744D0 (en) | Therapeutic agents | |
| GB201321742D0 (en) | Therapeutic agents | |
| GB201321735D0 (en) | Therapeutic Agents | |
| HK1217910A1 (zh) | 骨用生物特異性試劑 | |
| GB201321748D0 (en) | Therapeutic agents | |
| GB201321745D0 (en) | Therapeutic agents | |
| GB201321731D0 (en) | Therapeutic agents | |
| GB201308440D0 (en) | Therapeutic | |
| HK1223853A1 (zh) | 骨質疏鬆症治療劑 | |
| GB201321749D0 (en) | Therapeutic agents | |
| GB201318668D0 (en) | Sonosensitive therapeutic |